Nurofen Rapid Relief 200mg Liquid Capsules

*
Pharmacy Only: Non-prescription
  • Company:

    Reckitt Benckiser Ireland Limited
  • Status:

    No Recent Update
  • Legal Category:

    Supply through pharmacy only
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 23 October 2021

File name

Nurofen Rapid Relief 200mg SmPC Apr21.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category:Supply through pharmacy only

Updated on 23 October 2021

File name

Nurofen Rapid Relief 200mg SmPC Apr21.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category:Supply through pharmacy only

Updated on 23 October 2021

File name

Nurofen Rapid Relief 200mg PIL Apr21.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Updated on 02 April 2020

File name

IE SPC Nurofen 200mg Rapid Relief Mar 2020.pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects

Legal category:Supply through pharmacy only

Updated on 02 April 2020

File name

Rapid Relief 200mg Liquid Capsules PIL.pdf

Reasons for updating

  • Change to section 4 - possible side effects

Updated on 15 January 2020

File name

Nurofen Rapid Relief 200mg Liquid Capsules.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 19 December 2018

File name

Nurofen Rapid Relief 200mg Liquid Capsules PIL Oct 2018.pdf

Reasons for updating

  • Change to name of medicinal product

Updated on 19 December 2018

File name

Nurofen Rapid Relief 200mg Liquid Capsules SPC Oct 2018.pdf

Reasons for updating

  • Change to section 1 - Name of medicinal product

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Name change

Updated on 04 December 2017

Reasons for updating

  • New SPC for new product

Legal category:Supply through pharmacy only

Updated on 04 December 2017

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 3 - Pharmaceutical form
  • Change to section 9 - Date of first authorisation/renewal of the authorisation

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 1 Updated from Trade Name of the medicinal product to name of the medicinal product
Section 3 Liquid Capsule  changed to capsule soft
Renewal - date of last renewal updated to 23rd July 2014

Updated on 16 August 2017

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 4.2, 4.3, 4.4, 4.5, 4.8, 5.1 updated with Article 31 text
Section 4.4 and 4.8 updated with chicken pox warning
Section 10 updated date of revision of text

Updated on 15 August 2017

File name

PIL_14378_426.pdf

Reasons for updating

  • New PIL for new product

Updated on 15 August 2017

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects

Updated on 07 May 2015

Reasons for updating

  • Change to drug interactions

Updated on 06 May 2015

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Sections updated in  line with core safety information

Updated on 10 February 2015

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 6.1 - List of excipients

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 2 69.8mg of sorbitol change to 42.1 and 0.56mg of ponceau changed to 0.485mg
Section 4.4 sorbitol content updated to 42.1mg. Ponceau warning added
Section 6.1 fractionated cocunut oil and phos[hatidycholine and phosal 53MCT deleted and isopropyl alcohol and nitrogen added.

printing ink NSP7818022 and polyvinyl acetate phthalate, polyethylene glycol 400 deleted/ WB white NS-78-18011, isopropyl alcohol and HPMC 2910/hypromellose 3cP added

Updated on 10 October 2014

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Updated in relation to Article 45

Updated on 07 October 2014

Reasons for updating

  • Change to warnings or special precautions for use
  • Change to dosage and administration

Updated on 29 July 2014

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 6,5 rewording of this section,

Updated on 04 September 2013

Reasons for updating

  • Change of inactive ingredient

Updated on 15 May 2013

Reasons for updating

  • Change to section 6.1 - List of excipients
  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 6.1 List of Excipients, under Capsule shell, added Lecithin and Fractionated coconut oil or Phosphatidycholine in Medium Chain Triglycerides (Phosal 53 MCT).

In section 10, updated Date of revision of the text to May 2013

Updated on 08 February 2012

Reasons for updating

  • Change due to user-testing of patient information

Updated on 03 September 2009

Reasons for updating

  • New SPC for new product

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

None provided

Updated on 26 August 2009

Reasons for updating

  • New PIL for new product